story of the week
Ocrelizumab Wearing-Off Phenomenon Is Associated With Reduced Immunomodulatory Response and Increased Neuroaxonal Damage in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis
J Neurol 2024 May 23;[EPub Ahead of Print], I Monteiro, V Nicolella, M Fiorenza, F Novarella, A Carotenuto, R Lanzillo, L Mauriello, G Scalia, G Castaldo, D Terracciano, V Brescia Morra, M MocciaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.